Crosstalk Between Apoptosis and Antioxidants in Melanoma Vasculogenic Mimicry

  • Amalia Vartanian
  • Anatoly Yu. Baryshnikov
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 601)


The concept of “vasculogenic mimicry” (VM) was introduced to describe the unique ability of highly aggressive tumor cells to form capillary-like structure (CLS) and matrix-rich patterned network in three-dimensional cultures that mimic embryonic vasculogenic network. Here, we provide the experimental evidence that CLS structure formation requires apoptotic cell death through activation of caspase-dependent mechanism. Our results indicate that the formation of CLS is also related to the reactive oxygen species (ROS) levels.


Melanoma Cell Reactive Oxygen Species Level Vasculogenic Mimicry Skeletal Muscle Differentiation Intracellular Peroxide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Brakenhielm, E., Cao, R. and Cao, Y. (2002) Suppression of angiogenesis, tumor growth and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB J. 15, 1798–1800.Google Scholar
  2. De Botton, S., Sabri, S., Daugas, E., Zermati, Y., Gudorti, J.E., Hermine, O. and Debili, N. (2002) Platelet formation is the consenquence of caspase activation within megakariocytes. Blood 100, 310–317.Google Scholar
  3. Demierre, M.F. and Natanson, L. (2003) Chemoprevention of melanoma: an unexpected strategy. J. Clin. Oncol. 21, 158–165.CrossRefPubMedGoogle Scholar
  4. Endl, E. and Gerdes J. (2000) Ki-67 protein: fascinating forms and unknown functions. Exp. Cell. Res. 257, 231–237.CrossRefPubMedGoogle Scholar
  5. Fernando, P., Kelly, J.F., Balazsi, K., Slack, R.S. and Megeney, L.A. (2002) Caspase-3 activity is required for skeletal muscle differentiation. Proc. Natl. Acad. Sci. U.S.A. 99, 11025–11030.CrossRefPubMedGoogle Scholar
  6. Folkman, J. (2003) Fundamental concepts of the angiogenic process. Curr. Mol. Med. 3, 643–651.CrossRefPubMedGoogle Scholar
  7. Forguson, K (2005) Melanoma. J. Cont. Educ. Nurs. 36, 242–243.Google Scholar
  8. Fujiki, H. (1999) Two stages of cancer prevention with green tea. J. Cancer Res. Clin. Oncol. 125, 589–597.CrossRefPubMedGoogle Scholar
  9. Garcia-Garcia, J., Micol, V., de Godes, A. and Gomez-Fernandes, J.C. (1999) The cancer chemopreventive agent resveratrol is incorporated into model membranes and inhibits protein kinase C alpha activity. Arch. Biochem. Biophys. 372, 382–388.CrossRefPubMedGoogle Scholar
  10. Hendrix, M.J., Seftor, E.A., Hess, A.R. and Seftor, R.E. (2003) Molecular plasticity of human melanoma cells. Oncogene 22, 3070–3075.CrossRefPubMedGoogle Scholar
  11. Jang, M., Cai, L., Udeani, G.O., Slowing, K.V., Thomas, C.F., Beecher, C.W. and Pezzuto, J.M. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275, 218–220.CrossRefPubMedGoogle Scholar
  12. Lamy, S., Gingras, D. and Beliveau, R. (2002) Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation. Cancer Res. 62, 381–385.PubMedGoogle Scholar
  13. Mandara, M., Nortilli, R., Sava, T. and Cetto, G.L. (2006) Chemotherapy for metastatic melanoma. Expert Rev. Anticancer Ther. 6, 121–130.CrossRefPubMedGoogle Scholar
  14. Maniotis, A., Folberg, R., Hess, A., Seftor, E.A., Gardner, L.M., Pe’er, J. and Hendrix, M.J. (1999) Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am. J. Pathol. 55, 739–752.Google Scholar
  15. Maniotis, A.J., Chen, X., Garcia, C., deChristopher, P.J., Wu, D. and Folberg, R. (2002) Control of melanoma morphogenesis, endothelial survival and perfusion by extracellular matrix. Lab. Invest. 82, 1031–1043.PubMedGoogle Scholar
  16. Manna, S.K., Mukhopadhyay, A. and Aggarwal, B.B. (2000) Resveratrol suppresses TNF-induced activation of NF-kappa B, activator protein-1 and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol. 164, 6509–6519.PubMedGoogle Scholar
  17. Meier, P., Finch, A. and Evan, G. (2000) Apoptosis in development. Nature 407, 796–801.CrossRefPubMedGoogle Scholar
  18. Meykens, F.L., Farmer, P. and Fruehanf, J.P. (2001) Redox regulation in human melanocytes and melanoma. Pigment Cell Res. 14, 148–152.CrossRefGoogle Scholar
  19. Mikhailova, I.N., Lukashina, M.I., Baryshnikov, A.Yu., Morozova, L.F., Burova, O.S., Kiselev, S. and Georgiev, G.P. (2005) Melanoma cell line as a basis for antitumor vaccine preparation. Vest. Ross. Akad. Med. Nauk [Rus] 7, 37–40.Google Scholar
  20. Mogi, M. and Togari, A. (2003) Activation of caspases is required for osteoblastic differentiation. J. Biol. Chem. 278, 47477–47482.CrossRefPubMedGoogle Scholar
  21. Mukhtar, H. and Ahmad, N. (1999) Green tea in chemoprevention of cancer. Toxicol. Sci. 52, 111–117.PubMedGoogle Scholar
  22. Schulze-Osthoff, K., Ferrari, D. and Loss, M. (1998) Apoptosis signaling by death receptors. Eur. J. Biochem. 17, 1675–1687.Google Scholar
  23. Soleas, G.J., Diamandis, E.P. and Goldbery, D.M. (1997) Resveratrol: a molecule whose time has come? And gone? Clin. Biochem. 30, 91–113.CrossRefPubMedGoogle Scholar
  24. Sordet, O., Rebe, C., Plenchette, S., Hermine, O., Vanchenker, W. and Dubrez-Daloz, L. (2002) Specific involvement of caspases in the differentiation of monocytes into macrophages. Blood 100, 4446–4453.CrossRefPubMedGoogle Scholar
  25. Stone, J.R. and Collins, T. (2002) The role of hydrogen peroxide in endothelial proliferative response. Endothelium 9, 231–238.CrossRefPubMedGoogle Scholar
  26. Van der Schaft, D.W., Seftor, R.B., Seftor, E.A., Hess, A.R., Gruman, L.M., Kirschmann, D.A. and Hendrix, M.J. (2004) Effects of angiogenesis inhibitors on vascular network formation by human endothelial and melanoma cells. J. Natl. Cancer Inst. 96, 1473–1476.CrossRefPubMedGoogle Scholar
  27. Warso, M.A., Maniotis, A.J., Chen, X., Majumdar, D., Patel, M.K., Shilkaitis, A. and Folberg, R. (2001) Prognostic significance of Periodic acid-Schiff-positive patterns in primary cutaneous melanoma. Clin. Cancer Res. 7, 473–377.PubMedGoogle Scholar
  28. Yasuda, M., Ohzeki, Y., Shimizu, S., Naito, S., Ohtsuru, A., Yamamoto, T. and Kuroiwa, Y. (1999) Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with ETS-1 in endothelial cells. Life Sci. 64, 249–258.CrossRefPubMedGoogle Scholar
  29. Zermati, Y., Garrido, C., Amsellem, S., Fashelson, S., Bouscary, D., Valenci, F. and Hermine, O. (2001) Caspase activation is required for terminal erytroid differentiation. J. Exp. Med. 193, 247–254.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  1. 1.Department of Experimental Diagnosis and Biotherapy of TumorsRussian Cancer Research CenterMoscowRussia

Personalised recommendations